Miramar Capital, LLC Oncternal Therapeutics, Inc. Transaction History

Miramar Capital, LLC

  • $428 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022
SELL
$0.7 - $1.56 $700 - $1,560
-1,000 Reduced 7.74%
11,920 $13,000
Q1 2022

May 10, 2022
BUY
$1.37 - $2.43 $17,700 - $31,395
12,920 New
12,920 $18,000

Others Institutions Holding ONCT

# of Institutions
3
Shares Held
362K
Call Options Held
0
Put Options Held
0
View Full List

About Oncternal Therapeutics, Inc.

ONCT Quotes by TradingView
  • Ticker ONCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,517,200
  • Market Cap $29.4M
  • Description
  • Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...
More about ONCT
Track This Portfolio

Track Miramar Capital, LLC Portfolio

Follow Miramar Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miramar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miramar Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email